Website profile

The Globe and Mail

The Globe and Mail offers the most authoritative news in Canada, featuring national and international news

  • 5,221articles · 30d
  • 13+ hour agolatest article
  • Aug 15, 2026earliest in window
  • 73%with images · 113 videos
  • 283avg words
articles per day
Categories
  • Economy, Business & Finance 3,938
  • Finance & Business 3,701
  • News 1,943
  • Finance 1,506
  • Politics 504
  • Business & Industrial 487
  • Politics2 325
  • Sports 209

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


theglobeandmail.com > investing > markets > markets-news > ACN > 4005950 > public-healthcare-companies-meet-institutional-investors-at-the-5th-annual-roth-healthcare-opportunities-conference

Public Healthcare Companies Meet Institutional Investors at the 5th Annual ROTH Healthcare Opportunities Conference

3+ week, 1+ hour ago   (232+ words) B2i Digital, Inc. serves as Marketing Partner for the 5th Annual ROTH Healthcare Opportunities Conference, hosted by ROTH Capital Partners and held at The Metropolitan Club in New York City on Tuesday, September 29, 2026. B2i Digital supports the conference through digital marketing, its media…...


theglobeandmail.com > investing > markets > markets-news > motley > 3940892 > why-moderna-stock-skyrocketed-today

Why Moderna Stock Skyrocketed Today

3+ week, 4+ day ago   (427+ words) represent a pivotal moment for the field of cancer research. For many years, the idea of creating an mRNA...set to reach $275 billion by 2030, according to research from Nova One Advisor. Before you buy stock in...


theglobeandmail.com > investing > markets > stocks > NVS > pressreleases > 4517719 > will-the-recent-pipeline-progress-boost-bmys-portfolio-expansion

Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?

5+ day, 1+ hour ago   (542+ words) Arlo-cel is a potential first-in-class autologous G protein-coupled receptor class C group 5 member D (GPRC5D)-directed CAR T cell therapy. Quadruple-class exposure consists of those who have been treated with an immunomodulatory inhibitor, a proteasome inhibitor, an anti-CD38 therapy and a…...


theglobeandmail.com > investing > markets > markets-news > Newsfile > 3928030 > ratedbypatients-launches-price-comparison-site-for-u-s-telehealth-medications-and-pharmacies

RatedByPatients Launches Price Comparison Site for U.S. Telehealth, Medications and Pharmacies

3+ week, 5+ day ago   (371+ words) The independent review site publishes hand-checked prices for 154 telehealth providers and 78 medications, and scores every provider on one published formula that no company can pay to change Marlborough, United Kingdom--(Newsfile Corp. - August 19, 2026) - RatedByPatients today launched a free comparison site…...


theglobeandmail.com > investing > markets > stocks > LLY-N > pressreleases > 4384299 > this-new-zepbound-study-could-be-great-news-for-eli-lilly-investors

This New Zepbound Study Could Be Great News for Eli Lilly Investors

1+ week, 5+ day ago   (281+ words) The results of a study Eli Lilly ran suggest that patients older than 55 on Zepbound incur lower healthcare costs than those not on Zepbound. This could help the company make the case for expanded Zepbound coverage. There are multiple reasons…...


theglobeandmail.com > investing > markets > markets-news > Newsfile > 4362219 > dr-timothy-francis-scholarship-launches-national-application-cycle-for-future-medical-leaders-and-integrative-healthcare-innovators

Dr. Timothy Francis Scholarship Launches National Application Cycle for Future Medical Leaders and Integrative Healthcare Innovators

1+ week, 6+ day ago   (453+ words) The Globe and Mail Dr. Timothy Francis Scholarship Launches National Application Cycle for Future Medical Leaders and Integrative Healthcare Innovators Las Vegas, Nevada--(Newsfile Corp. - August 31, 2026) - The Dr. Timothy Francis Scholarship for Medical Students officially announces the opening of its…...


theglobeandmail.com > investing > markets > markets-news > Newswire.ca > 3941639 > ja-powers-fisher-paykel-healthcare-s-green-transition-with-new-zealand-s-largest-rooftop-pv-system

JA Powers Fisher & Paykel Healthcare's Green Transition with New Zealand's Largest Rooftop PV System

3+ week, 4+ day ago   (47+ words) The Globe and Mail JA Powers Fisher & Paykel Healthcare's Green Transition with New Zealand's Largest Rooftop PV System All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026....


theglobeandmail.com > investing > markets > markets-news > GlobeNewswire > 3904086 > rocket-doctor-enters-new-strategic-network-agreement-in-california-to-expand-access-across-multiple-u-s-healthcare-channels

Rocket Doctor Enters New Strategic Network Agreement in California to Expand Access Across Multiple U.S. Healthcare Channels

3+ week, 6+ day ago   (545+ words) The Globe and Mail Rocket Doctor Enters New Strategic Network Agreement in California to Expand Access Across Multiple U.S. Healthcare Channels - Agreement provides Rocket Doctor access across five network channels, including commercial healthcare, Medicare Advantage, workers’ compensation and auto medical. - National…...


theglobeandmail.com > investing > article-merck-moderna-skin-cancer-vaccine-trial-results

Moderna shares surge as melanoma vaccine with Merck succeeds in large trial

3+ week, 5+ day ago   (272+ words) Merck MRK-N and Moderna MRNA-Q said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced skin cancer recurrence and spread compared with Keytruda alone, the first positive late-stage trial results for an mRNA…...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.